Fractalkine is expressed by smooth muscle cells in response to IFN-γ and TNF-α and is modulated by metalloproteinase activity

Journal of Immunology

Volumn 168, Issue 2, 2002, Pages 604-612

  Ludwig, A ^a   Berkhout, T ^a   Moores, K ^a   Groot, P ^a   Chapman, G ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; CALCIUM; CELL ADHESION MOLECULE; CHEMOATTRACTANT; CHEMOKINE RECEPTOR; CX3C CHEMOKINE; FRACTALKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; MESSENGER RNA; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; ZINC DERIVATIVE;

ARTICLE; BLOOD VESSEL WALL; CALCIUM TRANSPORT; CELL ADHESION; CELL MEMBRANE; CELL MIGRATION; CELL STIMULATION; CELL SURFACE; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SMOOTH MUSCLE FIBER;

EID: 0037080042     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.2.604     Document Type: Article

References (40)

1. Chemokines: Immunology's high impact factors
2. Chemokines and disease
3. Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: Induction of the synthetic phenotype: A possible clue to SMC differentiation in the process of atherogenesis
4. Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells
5. Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques
6. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques
7. Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: Using genomic technology to identify a potential novel pathway of vascular inflammation
8. A new class of membrane-bound chemokine with a CX3C motif
9. Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions
10. Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells
11. Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation
12. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia
13. The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo
14. Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa
15. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage
16. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion
17. Identification of CX3CR1: A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1
18. MIP-3α. MIP-3β and fractalkine induce the locomotion and the mobilization of intracellular calcium, and activate the heterotrimeric G proteins in human natural killer cells
19. Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction: Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation
20. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow
21. The role of fractalkine in the recruitment of monocytes to the endothelium
22. Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor
23. Batimastat, a potent matrix metalloproteinase inhibitor, exhibits an unexpected mode of binding
24. Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B
25. Bioactive conformation of stromelysin inhibitors determined by transferred nuclear Overhauser effects
26. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions
27. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
28. CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms
29. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses
30. Synergistic stimulation, by tumor necrosis factor-α and interferon-γ, of fractalkine expression in human astrocytes
31. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes
32. Tumor necrosis factor-α-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)
33. Generation and analysis of mice lacking the chemokine fractalkine
34. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion
35. A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection
36. Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication
37. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease
38. Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis
39. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases
40. Expression of a disintegrin-like protein in cultured human vascular cells and in vivo